Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: Implications for cardiovascular risk

References

• Writing Group for the Women's Health Initiative Investiga-tors. Risks and benefits of estrogen plus progestogen in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321–33.
   Google Scholar
• Hulley S, Grady H, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progesto-gen for secondary prevention of heart disease in postmenopausal women. J Am Med Assoc 1998;280:605–13.
   Google Scholar
• Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933–41.
   PubMed Web of Science ®Google Scholar
• The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative Randomized Controlled Trial. J Am Med Assoc 2004;291:1701–12.
   Google Scholar
• Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med 2003;348:645–50.
   Google Scholar
• Horsmann A, Gallagher JC, Simpson M, Nordin BEC. Prospective trial of oestrogen and calcium in postmenopausal women. Br Med J 1977;ii:789–92.
   Google Scholar
• Christiansen C, Riis BJ, Nilas L, Rodbro P, Deftos L. Uncoupling of bone formation and resorption by combined oestrogen and progestogen therapy in postmenopausal osteo-porosis. Lancet 1985;ii:800–1.
   Google Scholar
• Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, Robinson V, Henry D, O'Connell D, Cranney A. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002;23:529–39.
   Google Scholar
• Janssen JAMJL, Stolk RP, Pols HAP, Grobbee DE, Lamberts SWJ. Serum total IGF-I, free IGF-I and IGFBP-1 levels in an elderly population. Arterioscler Thromb Vasc Biol 1998;18: 277–82.
   Google Scholar
• Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A, et al. Close relationship of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in 2 populations. Diabetologia 2001;44: 333–9.
   PubMed Web of Science ®Google Scholar
• Cruickshank JK, Heald AH, Anderson SG, Cade JE, Sampayo J, Riste LK, Greenhalgh A, Taylor W, Fraser W, White A, et al. The epidemiology of the insulin-like growth factor system in 3 ethnic groups. Am J Epidemiol 2001;154:504–13.
   Google Scholar
• Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50: 637–42.
   Google Scholar
• Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393–6.
   Google Scholar
• Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999;91:620–5.
   PubMed Web of Science ®Google Scholar
• Mohan S, Baylink DJ. Insulin-like growth factor system components and the coupling of bone formation to resorption. Horm Res 1996;45(Suppl 1):59–62.
   PubMedGoogle Scholar
• Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological functions. Endocr Rev 1995;16:3–34.
   PubMed Web of Science ®Google Scholar
• Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 1997;216:319–57.
   PubMed Web of Science ®Google Scholar
• Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor-I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002;106:939–44.
   Google Scholar
• Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silver-stein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Chin Endocrinol Metab 2004; 89:114–20.
   PubMed Web of Science ®Google Scholar
• Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002;359:1740–5.
   PubMed Web of Science ®Google Scholar
• Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563–6.
   PubMed Web of Science ®Google Scholar
• Heald A, Selby PL, White A, Gibson JM. Progestogens abrogate estrogen-induced changes in the insulin-growth factor axis. Am J Obstet Gynecol 2000;183:593–600.
   PubMed Web of Science ®Google Scholar
• Kloosterboer HJ, Vonk-Noordegraaf CA, Turpijn EW. Selectivity in progesterone and androgen receptor binding of progestogens used in oral contraceptives. Contraception 1988;38:325–32.
   PubMed Web of Science ®Google Scholar
• Gill MS, Whatmore AJ, Tillman V, White A, Addison GM, Price DA, Clayton PE. Urinary IGF and IGF binding protein-in children with disordered growth. Chin Endocrinol (Oxf) 1997;46:483–92.
   Google Scholar
• Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994;4(Suppl 1):11–19.
   PubMedGoogle Scholar
• Crosby SR, Anderton CD, Westwood M, Holly JMP, Cwyfan Hughes SC,Gibson JM, Morrison CA, Young RJ, White A. Measurement of insulin-like growth factor-II in human plasma using a specific monoclonal antibody-based two-site immunor-adiometric assay. J Endocrinol 1993;137:141–50.
   Google Scholar
• Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphorylation pattern of insulin-like growth factor binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Chin Endocrin Metab 1994;79: 1735–41.
   Google Scholar
• Yates AP, Laing I. Age-related increase in haemoglobin Al c and fasting plasma glucose is accompanied by a decrease in # cell function without change in insulin sensitivity: evidence from a cross-sectional study of hospital personnel. Diabet Med 2002;19:254–8.
   PubMed Web of Science ®Google Scholar
• Lemay A, Dodin S, Cédrin I, T-Lemay L. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate. Chin Endocrinol (Oxf) 1995;42:341–51.
   Google Scholar
• Janssen JA, Lamberts SW. The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible? Eur J Endocrinol 2002;146: 467–77.
   PubMed Web of Science ®Google Scholar
• Jones JI, Gockerman A, Busby Jr WH, Wright G, Clemmons DR. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the a5#1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1993;90: 10553–7.
   Google Scholar
• Rooman RPA, Op de Beeck L, Martin M, Van Doom J, Mohan S, Du Caju MVL. IGF-I, IGF-II, 'free' IGF-I and IGF binding proteins -2 to -6 during high dose oestrogen treatment in constitutionally tall girls. Eur J Endocrinol 2002;146:823–9.
   Google Scholar
• Conover CA, Johnstone EW, Turner RT, Evans GL, John Ballard FJ, Doran PM, Khosla S. Subcutaneous administra-tion of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Growth Horm IGF Res 2002;12: 178–83.
   Google Scholar